News Focus
News Focus
Followers 33
Posts 5441
Boards Moderated 0
Alias Born 03/25/2013

Re: Whalatane post# 123155

Tuesday, 02/27/2018 6:22:57 PM

Tuesday, February 27, 2018 6:22:57 PM

Post# of 447476
Well to be fair the company said the trial design was p-rate of 5.9%, but could be as low as 5.2%.

CG's statement is definitely different, but not sure it supersedes previous guidance from one comment. Would be interested in what others think on this.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News